Skip to main navigation Skip to search Skip to main content

Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma

  • Giorgia Mastrella
  • , Mengzhuo Hou
  • , Min Li
  • , Veit M. Stoecklein
  • , Nina Zdouc
  • , Marie N.M. Volmar
  • , Hrvoje Miletic
  • , Soren Reinhard
  • , Christel C. Herold-Mende
  • , Susanne Kleber
  • , Katharina Eisenhut
  • , Gaetano Gargiulo
  • , Michael Synowitz
  • , Angelo L. Vescovi
  • , Patrick N. Harter
  • , Josef M. Penninger
  • , Ernst Wagner
  • , Michel Mittelbronn
  • , Rolf Bjerkvig
  • , Dolores Hambardzumyan
    • Ulrich Schuller, Jorg Christian Tonn, Josefine Radke, Rainer Glass, Roland E. Kalin*
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

72 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Keyphrases